New study sheds light on mysterious gene that influences cardiovascular health

NewsGuard 100/100 Score

A new study from researchers at the University of Ottawa Heart Institute (UOHI), published today in Cell Reports, sheds light on a mysterious gene that likely influences cardiovascular health. After five years, UOHI researchers now know how one genetic variant works and suspect that it contributes to the development of heart disease through processes that promote chronic inflammation and cell division.

Researchers at the Ruddy Canadian Cardiovascular Genetics Centre had initially identified a variant in a gene called SPG7 as a potential contributor to coronary artery disease several years ago, but its role in multiple health processes made it difficult to tease out how it affects heart disease.

The gene holds instructions for producing a protein called SPG7. This protein resides in mitochondria-the small power plants of cells that produce the energy cells need to function. SPG7's role is to help break down and recycle other damaged proteins within the mitochondria.

Normally, SPG7 requires a partner protein to activate itself and start this breakdown process. But, in people who carry the genetic variant in question, SPG7 can activate itself in certain circumstances, leading to increased production of free radicals and more rapid cell division. These factors contribute to inflammation and atherosclerosis.

"We think this variant would definitely heighten the state of inflammation, and we know that inflammation affects diabetes and heart disease," said Dr. Stewart, Principal Investigator in the Ruddy Canadian Cardiovascular Genetics Centre and senior author of the study. "Interestingly, the variant also makes people more resistant to the toxic side effects of some chemotherapy drugs."

From an evolutionary perspective, this resistance could help such a genetic variant gain a stable place in the human genome. Between 13 and 15 per cent of people of European descent possess this variant.

"The idea of mitochondria contributing to inflammation isn't new," concluded Dr. Stewart. "But what is new is that we've found one of the switches that regulate this process. We're excited, because once you know where the switches are, you can start looking for ways to turn them on and off."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New platform can deliver gene therapy precisely to specific areas of the brain